Form 4 for CRL Charles River Laboratories
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-04 · accession 0001100682-26-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-03-05 | 2026-03-04 | CRL | Girshick Birgit | COO, Corp. Executive VP | G - Gift | $0.00 | -328 | 40.4K | -0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | G | D | 328 | $0.00 | 40,417 | I Revocable Trust | — | — | (F1) Includes shares that were previously reported as directly held, which are now correctly reported as indirectly held. |